Stockreport

Evolus Sees Toxin Market Stabilizing, Evolysse Gaining Traction, Raises 2028 Revenue Targets at Conference [Yahoo! Finance]

Evolus, Inc.  (EOLS) 
Last evolus, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: us.evolis.com/investor-relations
PDF Its new HA product, Evolysse , is gaining traction—now in about 3,000 U.S. clinics with positive injector feedback on efficiency, control and duration, supported by han [Read more]